The differentiation effect of low‑dose cytosine arabinoside is disturbed in PU.1‑knockdown K562 cells

Nakano,Hiroko; Yanagita,Akane; Takahashi,Shinichiro

doi:10.3892/br.2014.265

The differentiation effect of low‑dose cytosine arabinoside is disturbed in PU.1‑knockdown K562 cells

Authors:
- Hiroko Nakano
- Akane Yanagita
- Shinichiro Takahashi
View Affiliations

Affiliations: Division of Hematology, Kitasato University School of Allied Health Sciences, Sagamihara, Kanagawa 252‑0373, Japan
Published online on: March 31, 2014 https://doi.org/10.3892/br.2014.265
Pages: 564-568

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We recently demonstrated by using PU.1‑knockdown K562 (K562 PU.1KD) cells stably expressing PU.1 short inhibitory RNAs and PU.1‑overexpressing K562 (K562 PU.1OE) cells, that therapeutic concentrations of 5‑aza‑2'‑deoxycytidine (5‑azadc) induce erythroid differentiation of these cells and that the PU.1 expression level is closely associated with the differentiating and apoptotic effects of 5‑azadc on K562 cells. In this study, we investigated whether the effects of low‑dose cytosine arabinoside (Ara‑C), which is another erythroid differentiation inducer in K562 cells, is associated with the expression level of PU.1 in these cells. As a result, we demonstrated that the effect of Ara‑C on cell viability and differentiation, as determined by the WST‑8 assay and β‑globin mRNA expression analysis, respectively, was suppressed in K562 PU.1KD cells compared to their controls. Collectively, these findings suggest that sufficient expression of PU.1 is indispensable for the erythroid differentiation of K562 cells.

View Figures

View References

1	Chen HM, Zhang P, Voso MT, et al: Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 85:2918–2928. 1995.PubMed/NCBI
2	Rosenbauer F, Wagner K, Kutok JL, et al: Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 36:624–630. 2004. View Article : Google Scholar : PubMed/NCBI
3	Pettersson M, Sundstrom C, Nilsson K and Larsson LG: The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. Blood. 86:2747–2753. 1995.PubMed/NCBI
4	Sokalski KM, Li SK, Welch I, Cadieux-Pitre HA, Gruca MR and DeKoter RP: Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia. Blood. 118:2801–2808. 2011. View Article : Google Scholar : PubMed/NCBI
5	Kihara-Negishi F, Suzuki M, Yamada T, Sakurai T and Oikawa T: Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain. Biochem Biophys Res Commun. 335:477–484. 2005. View Article : Google Scholar : PubMed/NCBI
6	Aoyama S, Nakano H, Danbara M, Higashihara M, Harigae H and Takahashi S: The differentiating and apoptotic effects of 2-aza-5′-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochem Biophys Res Commun. 420:775–781. 2012.PubMed/NCBI
7	Woessmann W, Zwanzger D and Borkhardt A: ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent. Cell Biol Int. 28:403–410. 2004. View Article : Google Scholar : PubMed/NCBI
8	Sztiller-Sikorska M, Jakubowska J, Wozniak M, Stasiak M and Czyz M: A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells. Br J Pharmacol. 157:1451–1462. 2009. View Article : Google Scholar : PubMed/NCBI
9	Iseki Y, Imoto A, Okazaki T, Harigae H and Takahashi S: Identification of annexin 1 as a PU.1 target gene in leukemia cells. Leuk Res. 33:1658–1663. 2009. View Article : Google Scholar : PubMed/NCBI
10	Imoto A, Okada M, Okazaki T, Kitasato H, Harigae H and Takahashi S: Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. J Biol Chem. 285:10300–10309. 2010. View Article : Google Scholar : PubMed/NCBI
11	Iseki Y, Nakahara M, Kubo M, Obata F, Harigae H and Takahashi S: Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells. Int J Mol Med. 29:319–323. 2012.PubMed/NCBI
12	Takahashi S, Harigae H, Kameoka J, Sasaki T and Kaku M: AML1B transcriptional repressor function is impaired by the Flt3 internal tandem duplication. Br J Haematol. 130:428–436. 2005. View Article : Google Scholar : PubMed/NCBI
13	Rao G, Rekhtman N, Cheng G, Krasikov T and Skoultchi AI: Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation. Oncogene. 14:123–131. 1997. View Article : Google Scholar : PubMed/NCBI
14	Yamada T, Kondoh N, Matsumoto M, Yoshida M, Maekawa A and Oikawa T: Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood. 89:1383–1393. 1997.PubMed/NCBI
15	Yamada T, Abe M, Higashi T, et al: Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. Blood. 97:2300–2307. 2001. View Article : Google Scholar : PubMed/NCBI
16	Back J, Dierich A, Bronn C, Kastner P and Chan S: PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood. 103:3615–3623. 2004. View Article : Google Scholar : PubMed/NCBI
17	Wontakal SN, Guo X, Will B, et al: A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1. PLoS Genet. 7:e10013922011. View Article : Google Scholar : PubMed/NCBI
18	Takahashi S: Opposing role, depending on the stage, of PU.1 during erythroid differentiation. J Blood Lymph. 2:e1082012. View Article : Google Scholar
19	Donze D, Townes TM and Bieker JJ: Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J Biol Chem. 270:1955–1959. 1995. View Article : Google Scholar : PubMed/NCBI
20	Wall L, Destroismaisons N, Delvoye N and Guy LG: CAAT/enhancer-binding proteins are involved in beta-globin gene expression and are differentially expressed in murine erythroleukemia and K562 cells. J Biol Chem. 271:16477–16484. 1996. View Article : Google Scholar : PubMed/NCBI